National Cancer Action Center

ACS CAN released two reports today which provide a snapshot of utilization management requirements for specific cancer drugs in both the Medicare Part D plans and Medicare Advantage plans with drug coverage.

Federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House. Sponsored by Reps. Raul Ruiz (D-Calif.) and Larry Bucshon (R-Ind.), the Clinical Trial Modernization Act is bipartisan legislation that would increase access to clinical trials by helping remove cost and geographic barriers to patient participation.

Nearly half (49%) of cancer patients and survivors report being burdened by medical debt alongside some (13%) who report expecting to incur medical debt as part of their treatment plan, according to a new Survivor Views survey by the American Cancer Society Cancer Action Network (ACS CAN).

Today, the U.S. Department of Health and Human Services (HHS) finalized a new rule to expand insurance coverage eligibility to Deferred Action for Childhood Arrivals (DACA) recipients.